This study will prospectively investigate the feasibility, safety, and transfusion
requirements of adding hydroxyurea to simple chronic transfusions for patients with sickle
cell anemia already on chronic transfusions.
Phase:
Phase 2
Details
Lead Sponsor:
Children's National Research Institute Children's Research Institute